| Selectins promote tumor metastasis H Läubli, L Borsig Seminars in cancer biology 20 (3), 169-177, 2010 | 563 | 2010 |
| A red meat-derived glycan promotes inflammation and cancer progression AN Samraj, OMT Pearce, H Läubli, AN Crittenden, AK Bergfeld, K Banda, ... Proceedings of the National Academy of Sciences 112 (2), 542-547, 2015 | 467 | 2015 |
| Sialic acids in cancer biology and immunity OMT Pearce, H Läubli Glycobiology 26 (2), 111-128, 2016 | 466 | 2016 |
| The immune system and cancer evasion strategies: therapeutic concepts S Muenst, H Läubli, SD Soysal, A Zippelius, A Tzankov, S Hoeller Journal of internal medicine 279 (6), 541-562, 2016 | 386 | 2016 |
| Association of checkpoint inhibitor–induced toxic effects with shared cancer and tissue antigens in non–small cell lung cancer F Berner, D Bomze, S Diem, OH Ali, M Fässler, S Ring, R Niederer, ... JAMA oncology 5 (7), 1043-1047, 2019 | 367 | 2019 |
| Acute heart failure due to autoimmune myocarditis under pembrolizumab treatment for metastatic melanoma H Läubli, C Balmelli, M Bossard, O Pfister, K Glatz, A Zippelius Journal for immunotherapy of cancer 3 (1), 11, 2015 | 349 | 2015 |
| B cells sustain inflammation and predict response to immune checkpoint blockade in human melanoma J Griss, W Bauer, C Wagner, M Simon, M Chen, ... Nature communications 10 (1), 4186, 2019 | 337 | 2019 |
| Targeted glycan degradation potentiates the anticancer immune response in vivo MA Gray, MA Stanczak, NR Mantuano, H Xiao, JFA Pijnenborg, ... Nature chemical biology 16 (12), 1376-1384, 2020 | 281 | 2020 |
| Self-associated molecular patterns mediate cancer immune evasion by engaging Siglecs on T cells MA Stanczak, SS Siddiqui, MP Trefny, DS Thommen, KF Boligan, ... The Journal of clinical investigation 128 (11), 4912-4923, 2018 | 278 | 2018 |
| Involvement of a non-human sialic acid in human cancer AN Samraj, H Läubli, N Varki, A Varki Frontiers in oncology 4, 33, 2014 | 249 | 2014 |
| Engagement of myelomonocytic Siglecs by tumor-associated ligands modulates the innate immune response to cancer H Läubli, OMT Pearce, F Schwarz, SS Siddiqui, L Deng, MA Stanczak, ... Proceedings of the National Academy of Sciences 111 (39), 14211-14216, 2014 | 238 | 2014 |
| Altered cell adhesion and glycosylation promote cancer immune suppression and metastasis H Läubli, L Borsig Frontiers in immunology 10, 2120, 2019 | 235 | 2019 |
| L-Selectin Facilitation of Metastasis Involves Temporal Induction of Fut7-Dependent Ligands at Sites of Tumor Cell Arrest H Läubli, JL Stevenson, A Varki, NM Varki, L Borsig Cancer research 66 (3), 1536-1542, 2006 | 222 | 2006 |
| Selectin-mediated activation of endothelial cells induces expression of CCL5 and promotes metastasis through recruitment of monocytes H Läubli, KS Spanaus, L Borsig Blood, The Journal of the American Society of Hematology 114 (20), 4583-4591, 2009 | 174 | 2009 |
| Sialic acid–binding immunoglobulin-like lectins (Siglecs) detect self-associated molecular patterns to regulate immune responses H Läubli, A Varki Cellular and Molecular Life Sciences 77 (4), 593-605, 2020 | 163 | 2020 |
| Targeting sialic acid–Siglec interactions to reverse immune suppression in cancer OJ Adams, MA Stanczak, S von Gunten, H Läubli Glycobiology 28 (9), 640-647, 2018 | 158 | 2018 |
| Influenza vaccination of cancer patients during PD-1 blockade induces serological protection but may raise the risk for immune-related adverse events H Läubli, C Balmelli, L Kaufmann, M Stanczak, M Syedbasha, D Vogt, ... Journal for immunotherapy of cancer 6, 1-10, 2018 | 148 | 2018 |
| Siglec-9 Regulates an Effector Memory CD8+ T-cell Subset That Congregates in the Melanoma Tumor Microenvironment Q Haas, KF Boligan, C Jandus, C Schneider, C Simillion, MA Stanczak, ... Cancer immunology research 7 (5), 707-718, 2019 | 143 | 2019 |
| Targeting cancer glycosylation repolarizes tumor-associated macrophages allowing effective immune checkpoint blockade MA Stanczak, N Rodrigues Mantuano, N Kirchhammer, DE Sanin, ... Science translational medicine 14 (669), eabj1270, 2022 | 122 | 2022 |
| Lectin galactoside-binding soluble 3 binding protein (LGALS3BP) is a tumor-associated immunomodulatory ligand for CD33-related Siglecs H Läubli, F Alisson-Silva, MA Stanczak, SS Siddiqui, L Deng, A Verhagen, ... Journal of Biological Chemistry 289 (48), 33481-33491, 2014 | 122 | 2014 |
Alfred ZippeliusProfessor of Translational Oncology, Co-Head Medical OncologyПотвърден имейл адрес: usb.ch
